The Australian market has shown mixed performance recently, with the ASX200 closing up 0.3% at 8,099.9 points, driven by gains in the Materials and Real Estate sectors while Financials lagged behind. In this environment, identifying growth companies with high insider ownership can be crucial as it often signifies strong confidence from those closest to the business.
Top 10 Growth Companies With High Insider Ownership In Australia
Overview: Capricorn Metals Ltd is an Australian company focused on the evaluation, exploration, development, and production of gold properties with a market cap of A$2.36 billion.
Operations: Capricorn Metals generates revenue primarily from its Karlawinda gold project, which amounted to A$359.73 million.
Insider Ownership: 11.9%
Earnings Growth Forecast: 20.2% p.a.
Capricorn Metals has demonstrated robust growth, with earnings increasing significantly over the past year and forecasts indicating continued strong performance. The company's revenue is projected to grow at 18.7% annually, outpacing the broader Australian market. Recent announcements highlight a major expansion study at the Karlawinda Gold Project, which could further enhance production capacity and resource estimates. Insider ownership remains high, aligning management's interests with shareholders and potentially driving long-term value creation.
Overview: Mineral Resources Limited, with a market cap of A$7.47 billion, operates as a mining services company in Australia, Asia, and internationally through its subsidiaries.
Operations: Revenue Segments: The company generates revenue primarily from Mining Services (A$3.38 billion), Iron Ore (A$2.58 billion), Lithium (A$1.41 billion), Energy (A$16 million), and Other Commodities (A$19 million).
Insider Ownership: 11.7%
Earnings Growth Forecast: 38.7% p.a.
Mineral Resources has seen mixed financial performance, with net profit margins declining from 5.1% to 2.4%. Despite this, insider buying has outpaced selling over the past three months. The company is forecasted to achieve significant annual earnings growth of 38.7%, surpassing the Australian market's average of 12.3%. However, revenue growth is expected at a modest 7.3% annually. Recent earnings reported A$125 million in net income for FY2024, down from A$243 million last year.
Overview: PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in the United States, Australia, New Zealand, and internationally with a market cap of A$1.78 billion.
Operations: Revenue from the development, manufacturing, and commercialization of NovoSorb Technology is A$103.23 million.
Insider Ownership: 10.3%
Earnings Growth Forecast: 38.3% p.a.
PolyNovo has demonstrated strong financial performance, becoming profitable this year with net income of A$5.26 million compared to a net loss last year. The company’s earnings are forecast to grow significantly at 38.3% annually, outpacing the Australian market's average growth rate. Despite trading below its estimated fair value, PolyNovo's revenue is expected to grow slower than 20% per year but still faster than the market average. Recent collaborations and increased sales highlight its growth potential.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include ASX:CMM ASX:MIN and ASX:PNV.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]
